REGN

Regeneron Pharmaceuticals, Inc. NMS · REGN

$676.69 -2.25 (-0.33%)

Extended · +1.46σ Grade B

+ Compare Open in Sniper

Valuation

Market cap $70.9B

P/E (ttm) 16.5

Forward P/E 12.4

Beta (5y) 0.24

Shares out 103.0M

Div yield 0.56%

Profitability & returns

ROE 14.5%

Net margin 29.6%

FCF margin 21.9%

Debt / equity 0.09

Trading information

Last price $676.69

Day range $672.31 – $691.13

52-wk range $591.52 – $815.00

Avg volume 1.0M

RSI (2) 73.5

Trend zone Extended

52-week range · today's price

$591.52$815.00

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-07-30

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic mac…